Lionheart Health Named Finalist in Octane's 2025 Medical Technology Innovation Awards

Lionheart Health, Inc. has been recognized as a finalist in the category of Best Innovation in Medical Technology Life Sciences in Octane's prestigious High Tech Awards. This acknowledgment underscores the company's commitment to developing breakthrough healthspan longevity solutions through advanced bioelectric and biologics technologies.

The company's flagship development is a whole body regeneration chamber described as a "womb for adults" designed to extend healthspan longevity by 20 years. Powered by AI and precise robotics, this multi-modality device utilizes bioelectrically-controlled and enhanced biologics to regenerate multiple organs including hearts, kidneys, brains, livers, pancreas, lungs, and other critical systems. The technology represents a significant advancement in regenerative medicine with potential global implications for aging populations.

Lionheart Health's business model focuses on licensing its patented technology platform to qualified clinics worldwide. The company has secured FDA 510K market clearances for using targeted bioelectric stimulation to improve circulation, build and recover muscle strength, reduce pain and inflammation, treat arthritis, prevent blood clots, enhance exercise benefits, and improve stroke recovery. These applications are integrated into products addressing skin and hair health, sexual health vitality, joint pain recovery, rapid body toning, and chronic inflammation reduction.

Howard Leonhardt, Executive Chairman and Co-CEO, stated that this recognition demonstrates the company's dedication to advancing longevity and healthspan through innovation. The company's recent achievements include winning the AbbVie Allergan ULP Innovation in Medical Aesthetics Award, Medtech Outlook Stimulator Development of the Year 2025 Award, and being named one of 40 semi-finalists in the $101 million XPRIZE Healthspan Competition.

Lionheart Health is sponsoring The Klotho Conference in Irvine on September 15th and 16th, 2025. Visitors can register and learn about elevating klotho levels at http://www.klothoconference.com. The company's patented BodStim TM EMS suit has demonstrated the ability to substantially increase circulating klotho levels compared to ordinary exercise, with more information available at http://www.bodstim.com.

The Octane 2025 Technology Awards Ceremony will take place on Thursday, September 25th, 2025 in Irvine. This recognition positions Lionheart Health at the forefront of medical technology innovation with potential far-reaching impacts on healthcare delivery and human longevity worldwide.